Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children
Authors:
- Yvonne W. Van DalenYDYvonne W. Van Dalen
- Charlotte BlokhuisCharlotte Blokhuis
- Sophie CohenSCSophie Cohen
- Jacqueline A. Ter StegeJSJacqueline A. Ter Stege
- Charlotte E. TeunissenCTCharlotte E. Teunissen
- Jens KuhleJKJens Kuhle
- Neeltje A. KootstraNKNeeltje A. Kootstra
- Henriette J. ScherpbierHSHenriette J. Scherpbier
- Taco W. KuijpersTKTaco W. Kuijpers
- Peter ReissPRPeter Reiss
- Charles B.L.M. MajoieCMCharles B.L.M. Majoie
- Matthan W.A. CaanMCMatthan W.A. Caan
Open Access
- 1 March 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (12) , e3093
Abstract
Despite treatment with combination antiretroviral therapy (cART), cognitive impairment is still observed in perinatally HIV-infected children. We aimed to evaluate potential underlying cerebral injury by comparing neurometabolite levels between perinatally HIV-infected children and healthy controls. This cross-sectional study evaluated neurometabolites, as measured by Magnetic Resonance Spectroscopy (MRS), in perinatally HIV-infected children stable on cART (n = 26) and healthy controls (n = 36). Participants were included from a cohort of perinatally HIV-infected children and healthy controls, matched group-wise for age, gender, ethnicity, and socio-economic status. N-acetylaspartate (NAA), glutamate (Glu), myo-inositol (mI), and choline (Cho) levels were studied as ratios over creatine (Cre). Group differences and associations with HIV-related parameters, cognitive functioning, and neuronal damage markers (neurofilament and total Tau proteins) were determined using age-adjusted linear regression analyses. HIV-infected children had increased Cho:Cre in white matter (HIV-infected = 0.29 ± 0.03; controls = 0.27 ± 0.03; P value = 0.045). Lower nadir CD4+ T-cell Z-scores were associated with reduced neuronal integrity markers NAA:Cre and Glu:Cre. A Centers for Disease Control and Prevention (CDC) stage C diagnosis was associated with higher glial markers Cho:Cre and mI:Cre. Poorer cognitive performance was mainly associated with higher Cho:Cre in HIV-infected children, and with lower NAA:Cre and Glu:Cre in healthy controls. There were no associations between neurometabolites and neuronal damage markers in blood or CSF. Compared to controls, perinatally HIV-infected children had increased Cho:Cre in white matter, suggestive of ongoing glial proliferation. Levels of several neurometabolites were associated with cognitive performance, suggesting that MRS may be a useful method to assess cerebral changes potentially linked to cognitive outcomes.Keywords
This publication has 42 references indexed in Scilit:
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological DiseasesPLOS ONE, 2013
- HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS StudyPLOS ONE, 2013
- Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV InfectionPLOS ONE, 2012
- Human Immunodeficiency Virus Disease Severity, Psychiatric Symptoms, and Functional Outcomes in Perinatally Infected YouthArchives of Pediatrics & Adolescent Medicine, 2012
- Lower brain glutamate is associated with cognitive deficits in HIV patients: A new mechanism for HIV‐associated neurocognitive disorderJournal of Magnetic Resonance Imaging, 2010
- Amyloid and tau cerebrospinal fluid biomarkers in HIV infectionBMC Neurology, 2009
- Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescentsAIDS, 2009
- N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiologyProgress in Neurobiology, 2007
- The neuropathogenesis of AIDSNature Reviews Immunology, 2005
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993